Anesthesia: Page 49

Milestone Scientific announces leadership changes

By DrBicuspid.com staff writers

Milestone Scientific has announced that Leslie Bernhard has been named chairman of the board. He succeeds Leonard Osser, who had served as chairman since 1991.

September 2, 2009

Propofol better than sevoflurane for pediatric patients?

By DrBicuspid.com staff writers

Is propofol better than sevoflurane as a general anesthesia for pediatric patients?

September 2, 2009

Jurors weigh jaw risk of osteoporosis drug Fosamax

By Reuters Health

NEW YORK (Reuters), Sep 3 - Jurors heard sharply different closing arguments on Wednesday in a trial over whether or not Merck & Co.'s Fosamax drug treatment for osteoporosis caused a Florida woman's jaw damage.

September 2, 2009

Articaine wins in mandibular infiltration study

By Laird Harrison

Will mandibular infiltration ever replace the inferior alveolar nerve block? Researchers have been picking away at this question for years. An article in this month's Journal of the American Dental Association brought them another step closer to the answer.

August 26, 2009

Milestone Scientific gets notice of allowance on patent

By DrBicuspid.com staff writers

The U.S. Patent and Trademark Office has issued a notice of allowance to Milestone Scientific for its U.S. patent application directed to the use of a disposable handpiece for fluid administration.

August 23, 2009

Lawyer recommends reporting drug-induced xerostomia to FDA

By DrBicuspid.com staff writers

Dentists should report cases of xerostomia caused by medications to the FDA, Edwin Zinman, D.D.S., J.D., told attendees at the World Congress of Minimally Invasive Dentistry annual meeting.

August 18, 2009

OraPharma offers dental students Arestin training

By DrBicuspid.com staff writers

OraPharma recently renewed the Arestin Student Access Program and created a new Professional Affairs Team to provide field support and instructor training for the program.

August 12, 2009

Milestone Scientific Q2 revenues up 52%

By DrBicuspid.com staff writers

Milestone Scientific reported an increase of 52% in net revenues for the second quarter of this year.

August 11, 2009

New osteoporosis drug may avoid osteonecrosis

By DrBicuspid.com staff writers

Denosumab, an investigational new drug for osteoporosis, increased patients' bone density without causing osteonecrosis of the jaw in a new study.

August 11, 2009

Merck denies Fosamax caused woman's ONJ

By DrBicuspid.com staff writers

Merck said it will "vigorously defend itself" in the first of what is expected to be several liability trials involving the company's osteoporosis drug Fosamax.

August 10, 2009

Computerized anesthetic system found equal to manual

By DrBicuspid.com staff writers

The Wand computer-controlled local anesthetic system from Milestone Scientific caused no more or less pain than conventional injections in a recent study.

August 10, 2009

Glibenclamide can discolor teeth in children with neonatal diabetes

By Reuters Health

NEW YORK (Reuters Health), Aug 10 - Glibenclamide (glyburide) use has been associated with tooth discoloration in at least five children treated for neonatal diabetes, according to a report in the August issue of Diabetes Care.

August 9, 2009

Previous Page

Page 49 of 56

Next Page